Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

Summary

CLO-SCB-1019-002 is the first study of SCB-1019T vaccine for revaccination in older adults who were previously vaccinated with AREXVY. The safety, tolerability and immunogenicity of SCB-1019T are assessed.

Timeline

Start

2025-03-21

Primary completion

2026-03-03

Completion

2026-06-03

Drugs

Indications